top of page
Dr. Mingzhe Ma - Gastric Surgeon - Fudan University Shanghai Cancer Center Shanghai

Professional Title & Qualifications:

Associate Chief Physician, MD, PhD

Specialization: 

Hospital & Department:

Fudan University Shanghai Cancer Center – Department of Gastric Surgery

Dr. Mingzhe Ma - Gastric Surgery Specialist

Personal Biography

Dr. Mingzhe Ma is a highly experienced Associate Chief Physician in the Department of Gastric Surgery at Fudan University Shanghai Cancer Center. He holds a Ph.D. in Oncology from Shanghai Jiao Tong University. Dr. Ma is a member of the International Gastric Cancer Association (IGCA) and the China Anti-Cancer Association (CACA).

He treats patients as if they were his own family, adhering to the principle of "everything for the patient." Dr. Ma has extensive clinical experience in performing complex gastric cancer surgeries with a low rate of complications. He is particularly renowned for his work in laparoscopic radical gastrectomy and function-preserving surgeries, which significantly improve patients' quality of life.

Dr. Ma has been selected for the "Shanghai Medical Star" program and the Harvard Medical School Global Clinical Scholars Research Training (GCSRT) program. He has also engaged in academic exchanges and visiting scholar programs at prestigious institutions globally, including Harvard Medical School's Dana-Farber Cancer Institute (USA), Linköping University (Sweden), and Jichi Medical University (Japan).

Book an online consultation with Dr. Mingzhe Ma

Areas of Expertise

  • Open and minimally invasive surgery for gastric tumors (including gastric cancer, antral cancer, corpus cancer, cardiac cancer, and gastrointestinal stromal tumors).

  • Pylorus-preserving and nerve-preserving gastrectomy.

  • Anti-reflux anastomosis for cardiac cancer (e.g., double-tract reconstruction).

  • Enhanced Recovery After Surgery (ERAS) for gastric cancer.

  • Minimally invasive treatment for early-stage gastric cancer.

  • Neoadjuvant and adjuvant therapy for advanced gastric cancer.

  • Conversion therapy for late-stage gastric cancer.

Clinical Highlights

  • Over 3,300 patients treated

  • 100% treatment satisfaction rate

  • 100% patient satisfaction with service attitude

Work Experience

  • Aug 2020 – Present: Associate Chief Physician, Fudan University Shanghai Cancer Center

  • Aug 2017 – Jul 2020: Attending Physician, Fudan University Shanghai Cancer Center

  • Aug 2015 – Jul 2017: Resident Physician, Fudan University Shanghai Cancer Center

Education

  • Ph.D. in Surgery: Shanghai Jiao Tong University

  • Master's in Clinical Medicine (7-year program): Shanghai Jiao Tong University

  • Bachelor's in Clinical Medicine (7-year program): Shanghai Jiao Tong University

Visiting Scholar Experience

  • Dec 2019 – Oct 2020: Global Clinical Scholars Research Training (GCSRT), Harvard Medical School, USA

  • Dec 2017 – Jan 2018: Jichi Medical University, Japan (Focus: Comprehensive treatment of gastric cancer with peritoneal metastasis)

  • Dec 2013 – May 2014: Dana-Farber Cancer Institute, Harvard Medical School, USA

  • Jun 2009 – Dec 2009: Linköping University, Sweden

Social Appointments

  • Member, Abdominal Surgery Committee, China Medicine Education Association

  • Member, Gastrointestinal Tumor Committee, Shanghai Anti-Cancer Association

  • Senior Editorial Board Member, World Journal of Gastrointestinal Surgery

  • Senior Editorial Board Member, World Journal of Gastroenterology

  • Senior Editorial Board Member, Frontiers in Oncology

  • Invited Reviewer, Molecular Therapy

Research Achievements

  • Published over 20 SCI papers in authoritative international journals such as Cancer Research, focusing on the clinical and biological behavioral characteristics of gastric cancer.

  • Presided over one National Natural Science Foundation of China (NSFC) Youth Project and one General Project.

  • Presided over one Shanghai Natural Science Foundation project.

  • Participated in the Shanghai Young Physician Training Plan.

  • Presented research findings on conversion therapy for advanced gastric cancer at major domestic and international conferences, including KINGCA (Korea International Gastric Cancer Week) and IGCC (International Gastric Cancer Congress).

Honors & Awards

  • 2021: Second Prize, Anhui Province Science and Technology Award (Ranked 3rd)

  • 2020: Outstanding Trainee Award, Shanghai Young Physician Training Plan

*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.

Need help scheduling your appointment with this specialist?

bottom of page